Executive leader with 30 years experience and expertise in a wide variety of life sciences area’s: Oncology, consortia building, CRO, Pharmaceutical, Biotech, Functional Food, Diagnostics and Medical Devices. Key roles in M&A and Venture Capital deal making. Driven by transforming Science into Value. Key leadership roles as Chairman of the Board, CEO, CCO, CSO and (Senior) Vice President in account, line, marketing, scientific and operational management for local and global companies. Success is driven by focus, commitment, getting it done, organizational talent and an intrinsic motivation to increase people’s personal performance. Board member of ACRON (Association CRO Netherlands), DCTF (Dutch Clinical Trial Foundation), Delphi Bioscience, EUCROF (European CRO Federation), Oncode Accelerator. Member of several Executive Steering Committees, both for large global pharma as biotech companies in Europe and USA. Managed several Phase I-IIa clinics in The Netherlands (including Clinical Operations, Project Management, Science, QA and Data Support, as well as ensuring GCP compliance) with succesfull delivery of appr. 250 phase I and IIa trials. P&L responsibility with record high EBITDA %. Leading role in several international mergers and acquisitions, including organizational integration.
Listed skills include Clinical Trials, Cro, Pharmaceutical Industry, Clinical Research, and 25 others.